Search Results for "Avesthagen Limited Cosmosid"

16:03 EDT 23rd March 2017 | BioPortfolio

Matching Channels


Sequencing platforms in diagnostic laboratories may aid both patient management by detecting resistance associated mutations, and public health measures, by determining phylogenetic relationships be...


India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...


Verona’s lead drug, RPL554, is a dual phosphodiesterase (PDE) 3 and 4 inhibitor being developed as a novel treatment for chronic obstructive airways disease as COPD (chronic obstructive pulmon...

Facebook - BioPortfolio Pages

BioPortfolio has launched a number of Facebook pages to allow our visitors to keep track with latest news, published paper and clinical trials by lead biotechnology and healthcare topics:- &nbs...


Coronavirus were first identified in the 1960s, and were named after the crown-like projections on the surface of the virus. They cause respiratory infections in both humans and animals. Coronavir...

Matching News

Qiagen and CosmosID launch metagenomics analysis plugin

The plugin for the Qiagen Microbial Genomics Pro Suite and CLC Genomics Workbench expands the firm's platform for NGS bioinformatics. Manoj Dadlani, CEO of CosmosID, said: " They start with raw se...

QIAGEN and CosmosID Launch New Plugin for Metagenomics Analysis

Bioinformatics expansion strengthens QIAGEN's Sample to Insight metagenomics solutions QIAGEN and CosmosID, a leading genomic big data company, today announced the launch of a metagenomics analysi...

QIAGEN, CosmosID launch new plugin for metagenomics analysis

QIAGEN and CosmosID have launched new metagenomics analysis plugin for the QIAGEN Microbial Genomics Pro Suite and CLC Genomics Workbench.

Avesthagen Limited Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

Project Synopsis:Datamonitor's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...

CosmosID Inc bioinformatics, cancer news

CosmosID Launches Metagenomic and Antibiotic Resistance Application in Thermo Fisher Cloud

CosmosID has made its automated metagenomics analysis solution available in the Thermo Fisher Cloud Rockville, MD (PRWEB) January 05, 2017 CosmosID has now made its automated metagenomics analysis so...

CosmosID Announces Oncobiome Partnership with the White House Cancer Moonshot Initiative

ROCKVILLE, Md., Oct. 17, 2016 /PRNewswire/ -- Today CosmosID announced participation in Vice President Biden's National Cancer Moonshot, which aims to accelerate progress in preventing, diagnosin...

Hutchison China Meditech Limited: Blocklisting Six Monthly Return

HONG KONG, CHINA -- (Marketwired) -- 12/29/16 -- Hutchison China Meditech Limited (NASDAQ: HCM) (AIM: HCM) Blocklisting Six Monthly Return London: Thursday, December 29, 2016: Hutchison China MediT...

Matching PubMed Articles


Search Whole site using Google

Quick Search
Advertisement Advertisement